UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Phase 1

Completed

Conditions: Leukemia
Breast Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Ovarian Cancer

Interventions: Drug: PS-341
Drug: Doxil
Drug: Velcade

First Posted Date: 2005-10-12

Last Posted Date: 2012-05-18

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 107

Registration Number: NCT00237627

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Procedure: PET (positron emission tomography)

First Posted Date: 2005-10-06

Last Posted Date: 2012-03-07

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 15

Registration Number: NCT00233974

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: docetaxel
Drug: leuprolide acetate
Radiation: radiation therapy

First Posted Date: 2005-09-23

Last Posted Date: 2017-06-01

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 23

Registration Number: NCT00225420

Locations: 🇺🇸
Rex Cancer Center at Rex Hospital, Raleigh, North Carolina, United States
🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

Phase 1

Completed

Conditions: Breast Cancer
Endometrial Cancer

Interventions: Dietary Supplement: Genistein
Dietary Supplement: Placebo

First Posted Date: 2004-12-09

Last Posted Date: 2013-05-21

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 30

Registration Number: NCT00099008

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2004-07-22

Last Posted Date: 2012-02-22

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 61

Registration Number: NCT00003392

Locations: 🇺🇸
Bone Marrow Stem Cell Transplant Institute of Florida, Fort Lauderdale, Florida, United States
🇺🇸
Lutheran General Cancer Care Center, Park Ridge, Illinois, United States
🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States

and more 11 locations

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Phase 1

Withdrawn

Conditions: Prostate Cancer

First Posted Date: 2004-04-20

Last Posted Date: 2012-04-24

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Registration Number: NCT00005827

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States

Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

First Posted Date: 2004-02-26

Last Posted Date: 2012-02-07

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Registration Number: NCT00006108

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

Phase 2

Terminated

Conditions: Prostate Cancer

First Posted Date: 2003-12-11

Last Posted Date: 2012-05-23

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 37

Registration Number: NCT00073970

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Biological: trastuzumab
Drug: doxorubicin hydrochloride
Drug: cyclophosphamide
Drug: paclitaxel
Procedure: conventional surgery

First Posted Date: 2003-01-27

Last Posted Date: 2017-07-31

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 82

Registration Number: NCT00006110

Locations: 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy